Meningitis outbreak reveals lack of oversight of some US drug pharmacies

According to new information from the Centers for Disease Control and Prevention today, the outbreak of fungal meningitis has spread. At least 11 people have died, another 119 are infected and as many as 13,000 people across the country are at risk of getting the rare disease from tainted medication. A federal investigation has linked the outbreak to the New England Compounding Center in Framingham, Massachusetts that manufactured the steroid injection used to cure back pain. Now, members of Congress and consumer advocates are demanding more regulation and oversight for the industry. In Washington, FSRN’s Alice Ollstein reports.